TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34388110

Group type: EXPERIMENTAL
Intervention: Avoidance Training (AvT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Placebo Training (PT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Approach Training (ApT)
Number of subjects: 45
Study: 32499757

Group type: EXPERIMENTAL
Intervention: Anastrozole (AI) plus weight loss (WL) at 1 mg daily for 6 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (PBO) plus weight loss (WL)
Number of subjects: 23
Study: 35151367

Group type: EXPERIMENTAL
Intervention: Active hexose correlated compound (AHCC)
Number of subjects: 230
Study: 34948580

Group type: EXPERIMENTAL
Intervention: Post-Isometric Relaxation (PIR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Myofascial Release (MR)
Number of subjects: 60
Study: 32597013

Group type: EXPERIMENTAL
Intervention: Let's Talk intervention
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Organizational capacity
Number of subjects: 8
Study: 34875139

Group type: EXPERIMENTAL
Intervention: QR678 Neo® hair growth factor formulation
Number of subjects: 20
Study: 32413581

Group type: EXPERIMENTAL
Intervention: varenicline only
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: varenicline + Prolonged Exposure (PE)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: baseline trauma cognitions
Number of subjects: 142
Study: 35680254

Group type: EXPERIMENTAL
Intervention: Youth Empowerment Skills (YES) programme
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 50
Study: 35770601

Group type: EXPERIMENTAL
Intervention: Cupping therapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 37
Study: 35102105

Group type: EXPERIMENTAL
Intervention: Elastic stable intramedullary nailing (ESIN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Submuscular locked plate (SMP)
Number of subjects: 40
Study: 32083979

Group type: EXPERIMENTAL
Intervention: Recreational Soccer Program (RSP)
Number of subjects: 13
Study: 32677375

Group type: EXPERIMENTAL
Intervention: Peramivir 600 mg on two consecutive days (peramivir-repeat)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Peramivir 300 mg single dose (peramivir-single)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Oseltamivir 75 mg twice daily for 5 days
Number of subjects: 214
Study: 32712083

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine
Number of subjects: 30522
Study: 34857578

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy alone
Number of subjects: 1900

Group type: COMPARATOR
Intervention: Adjuvant therapy plus axillary treatment (ANC or axillary RT)
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (standard care)
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Arm morbidity assessed by Lymphoedema and Breast Cancer Questionnaire and QuickDASH questionnaires
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Quality of life and anxiety assessed with FACT B+4 and State/Trait Anxiety Inventory questionnaires
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Economic evaluation using EQ-5D-5L
Number of subjects: 1900
Study: 36496126

Group type: EXPERIMENTAL
Intervention: Sonic-assisted diffusing group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ultrasonic-assisted diffusing group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (without treatment)
Number of subjects: 30
Study: 32684108

Group type: EXPERIMENTAL
Intervention: High-volume resistance training (HV-RT)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Low-volume resistance training (LV-RT)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Maximal isometric voluntary contraction (MIVC)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (CTRL)
Number of subjects: 58
Study: 32510754

Group type: EXPERIMENTAL
Intervention: N. sativa oil (1,000 mg daily for 8 weeks)
Number of subjects: 50
Study: 34928294

Group type: EXPERIMENTAL
Intervention: Daily low-dose prednisolone (15 mg/m2 daily for 6 days)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Daily low-dose prednisolone
Number of subjects: 365
Study: 33953213

Group type: EXPERIMENTAL
Intervention: Aiming method (group A)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Needle guide (group NG)
Number of subjects: 300
Study: 34728381

Group type: EXPERIMENTAL
Intervention: Micro-ultrasound guided biopsy
Number of subjects: 1200

Group type: COMPARATOR
Intervention: MRI/US fusion
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: MRI/MicroUS contour-less fusion
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: mpMRI targeted samples
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: microUS targeted samples
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: systematic samples
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Negative predictive value of microUS
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Negative predictive value of MRI
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Health economic analysis of microUS
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Health economic analysis of MRI/US fusion
Number of subjects: 1200
Study: 33927582

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil tablets (250 mg) - various brands
Number of subjects: 6
Study: 32197931

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking cessation interventions (intensive)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose thoracic CT scan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of smoking cessation and lung cancer screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36065795

Group type: EXPERIMENTAL
Intervention: Spironolactone (up to 50 mg/day)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 513
Study: 32146715

Group type: EXPERIMENTAL
Intervention: Compression orthosis 23 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compression orthosis 8 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32199866

Group type: EXPERIMENTAL
Intervention: Lampalizumab every 4 weeks
Number of subjects: 1881

Group type: EXPERIMENTAL
Intervention: Lampalizumab every 6 weeks
Number of subjects: 1881

Group type: COMPARATOR
Intervention: Sham every 4 weeks
Number of subjects: 1881

Group type: COMPARATOR
Intervention: Sham every 6 weeks
Number of subjects: 1881

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1881

Group type: EXPERIMENTAL
Intervention: Microperimetry outcomes
Number of subjects: 1881
Study: 36209245

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg in 100 ml isotonic saline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (100 ml isotonic saline only)
Number of subjects: 60
Study: 33422517

Group type: EXPERIMENTAL
Intervention: Immediate invasive strategy (<3 hours)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Early invasive strategy (12‐24 hours)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Immediate invasive strategy
Number of subjects: 249

Group type: COMPARATOR
Intervention: Early invasive strategy
Number of subjects: 249
Study: 32321483

Group type: EXPERIMENTAL
Intervention: Palliative Care Intervention (PCI) integrated with standard haematological care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard haematological care alone
Number of subjects: 60
Study: 35436810

Group type: EXPERIMENTAL
Intervention: Subanesthetic dose of esketamine 0.125 mg·kg‐1·h‐1 (group ES1)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Subanesthetic dose of esketamine 0.250 mg·kg‐1·h‐1 (group ES2)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Normal saline (Control group C)
Number of subjects: 71
Study: 35279940

Group type: EXPERIMENTAL
Intervention: Saccharide isomerate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33144386

Group type: EXPERIMENTAL
Intervention: Airway clearance techniques (20 min of prolonged slow expiration and provoked cough)
Number of subjects: 91

Group type: COMPARATOR
Intervention: High-frequency chest wall compression (HFCWC) (15 min)
Number of subjects: 91
Study: 35016205

Group type: EXPERIMENTAL
Intervention: DAV132 (7.5 g, 3 times a day, orally)
Number of subjects: 243

Group type: COMPARATOR
Intervention: No-DAV132
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: DAV132
Number of subjects: 243
Study: 33794784

Group type: EXPERIMENTAL
Intervention: VSL#3® probiotic supplementation (2 sachets twice daily for 10 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: VSL#3® probiotic supplementation
Number of subjects: 35
Study: 36007210

Group type: EXPERIMENTAL
Intervention: Audible alarm wristwatch
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no audible alarm)
Number of subjects: 100
Study: 32989783

Group type: EXPERIMENTAL
Intervention: Hair Follicle Cell Suspension (HFCS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Epidermal Cell Suspension (ECS)
Number of subjects: 20
Study: 34982819

Group type: EXPERIMENTAL
Intervention: 1600 IU/day vitamin D3
Number of subjects: 2495

Group type: EXPERIMENTAL
Intervention: 3200 IU/day vitamin D3
Number of subjects: 2495

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2495
Study: 32391548

Group type: EXPERIMENTAL
Intervention: CEMA cutpoint of 27 pmol/mL urine
Number of subjects: 2450

Group type: COMPARATOR
Intervention: Different cotinine cutpoints (10-30 ng/mL)
Number of subjects: 2450
Study: 34302474

Group type: EXPERIMENTAL
Intervention: Mailed plan
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Plan delivered during a 1‐time transition visit
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Plan delivered during a transition visit plus 6‐month follow‐up visit
Number of subjects: 378
Study: 33770484

Group type: EXPERIMENTAL
Intervention: Dexamethasone plus oseltamivir (40 mg/day for 4 days + 75 mg twice a day for 10 days)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Dexamethasone (40 mg/day for 4 days)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Dexamethasone plus oseltamivir
Number of subjects: 96

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 96
Study: 35732380

Group type: EXPERIMENTAL
Intervention: ezParent
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: ezParent + coach
Number of subjects: 220

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 220

Group type: COMPARATOR
Intervention: Active Control + coach
Number of subjects: 220
Study: 33587135

Group type: COMPARATOR
Intervention: Tai Chi
Number of subjects: 320

Group type: COMPARATOR
Intervention: Conventional Exercise
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Control
Number of subjects: 320
Study: 33357531

Group type: EXPERIMENTAL
Intervention: RDN
Number of subjects: 146
Study: 35961850

Group type: EXPERIMENTAL
Intervention: synthetic osmotic cervical dilator
Number of subjects: 0

Group type: COMPARATOR
Intervention: dinoprostone vaginal insert
Number of subjects: 0
Study: 33599773

Group type: EXPERIMENTAL
Intervention: AI-enabled patient decision aid including education, preference assessment, and personalized outcome estimations
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: AI-enabled patient decision aid
Number of subjects: 129

Group type: COMPARATOR
Intervention: Educational material only (control)
Number of subjects: 129
Study: 35379294

Group type: EXPERIMENTAL
Intervention: Mobile physical activity intervention for YACS
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Unpaid social media posts
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Direct mail
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Other social media, email, clinic referrals, conference advertisements
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Cost-effective methods
Number of subjects: 280
Study: 33556109

Group type: EXPERIMENTAL
Intervention: Cold stress (CT) in Longyou7 (L7)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Cold stress (CT) in Tianyou2 (T2)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cold stress (CT)
Number of subjects: 2
Study: 35146785

Group type: EXPERIMENTAL
Intervention: Pendulum exercise (PE)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Stretching and strengthening exercises (SSE)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study: 32657903

Group type: EXPERIMENTAL
Intervention: Massage application with lavender oil (n = 15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Massage application with ultrasound gel (placebo, n = 15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 45
Study: 32390705

Group type: EXPERIMENTAL
Intervention: 1 L-PEG preparation (Plenvu®)
Number of subjects: 1289

Group type: COMPARATOR
Intervention: 2 L-PEG preparation (Moviprep® or Clensia®)
Number of subjects: 1289

Group type: COMPARATOR
Intervention: 4 L-PEG preparation (Selgesse®)
Number of subjects: 1289
Study: 35153168

Group type: EXPERIMENTAL
Intervention: Improved sleep trajectory
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Each additional hour of sleep
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: 1% increase in sleep efficiency
Number of subjects: 470
Study: 32567652

Group type: EXPERIMENTAL
Intervention: Machine learning-based methods for disease gene prediction (including binary classification, unary classification, semi-supervised classification, ensemble learning, matrix factorization, and deep learning)
Number of subjects: 0
Study: 36104660

Group type: EXPERIMENTAL
Intervention: Early essential newborn care
Number of subjects: 182

Group type: COMPARATOR
Intervention: Routine birth care
Number of subjects: 182
Study: 33772849

Group type: EXPERIMENTAL
Intervention: +0.50DS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: +1.00DS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Retro-reflective vest
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Thin biomotion clothing
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Thick biomotion clothing
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All blur levels
Number of subjects: 20
Study: 32284062

Group type: EXPERIMENTAL
Intervention: Dynamic Compression Locking System (DCLS)
Number of subjects: 54
Study: 35193666

Group type: EXPERIMENTAL
Intervention: Individualized and goal-oriented intervention targeting everyday functioning of the child and family, consisting of seven family sessions, one parent seminar, and four school sessions delivered over approximately 6 months.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (details not specified in the abstract).
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Individualized and goal-oriented intervention.
Number of subjects: 70
Study: 34313917

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 0.4 mg/kg, acetaminophen 1g, ondansetron 4 mg
Number of subjects: 82
Study: 32661108

Group type: EXPERIMENTAL
Intervention: Afrezza high dose (AH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Afrezza low dose (AL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard SC rapid-acting insulin (aspart)
Number of subjects: 0
Study: 616084148

Group type: EXPERIMENTAL
Intervention: Half-dose verteporfin photodynamic therapy (hd-PDT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 689 nm laser treatment
Number of subjects: 20
Study: 36465283

Group type: EXPERIMENTAL
Intervention: Mindfulness Living With Challenge (MLWC) intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 32646811

Group type: EXPERIMENTAL
Intervention: Hands On Surgical Training course in congenital heart surgery, including assisting a congenital heart surgeon and using 3D-printed models.
Number of subjects: 15
Study: 35315804

Group type: EXPERIMENTAL
Intervention: Patellofemoral arthroplasty (PFA)
Number of subjects: 100
Study: 34330846

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 996

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 996

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg no load
Number of subjects: 996

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 996
Study: 32653031

Group type: EXPERIMENTAL
Intervention: Monthly administration of solid forms (tablets, capsules)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Weekly administration of solid forms (tablets, capsules)
Number of subjects: 97
Study: 33866313

Group type: EXPERIMENTAL
Intervention: Sitagliptin + NB-UVB
Number of subjects: 118

Group type: COMPARATOR
Intervention: NB-UVB alone
Number of subjects: 118
Study: 32807403

Group type: EXPERIMENTAL
Intervention: Sintering at 1350 °C
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Sintering at 1600 °C
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Sintering at 1450 °C
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Sintering at 1550 °C
Number of subjects: 240
Study: 35146694

Group type: EXPERIMENTAL
Intervention: Antenatal glucocorticoids (betamethasone - BMZ)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 32416718

Group type: EXPERIMENTAL
Intervention: Community volunteers as extensions of primary care teams
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Volunteer training
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Intergenerational volunteer pairing
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Understanding the volunteer role
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Volunteers as extensions of primary care teams
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Disconnect between volunteers and clinical team
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Learning impacts on volunteers
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Clients' acceptance of volunteers
Number of subjects: 94
Study: 34046989

Group type: EXPERIMENTAL
Intervention: Oleanolic acid (OA) group: fluoride toothpaste containing 0.1% OA and placebo mouthwash
Number of subjects: 99

Group type: COMPARATOR
Intervention: Negative control group: fluoride toothpaste and placebo mouthwash
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: CHX group: fluoride toothpaste and 0.12% chlorhexidine mouthwash
Number of subjects: 99
Study: 36268811

Group type: EXPERIMENTAL
Intervention: Staccato alprazolam 1.0 mg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Staccato alprazolam 2.0 mg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Staccato placebo
Number of subjects: 116
Study: 33040561

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 μg/kg (Rem group, n=51)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Propofol 1.0 mg/kg (Pro group, n=48)
Number of subjects: 99
Study: 32160238

Group type: EXPERIMENTAL
Intervention: Journal readership
Number of subjects: 55

Group type: COMPARATOR
Intervention: Prestige and related metrics (impact factor)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Total number of publications, number of publications per year, journal name recognition
Number of subjects: 55
Study: 34506694

Group type: EXPERIMENTAL
Intervention: Yoga intervention (90 min sessions for 12 weeks, six days per week)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Physical exercise intervention (90 min sessions for 12 weeks, six days per week)
Number of subjects: 96
Study: 32901440

Group type: EXPERIMENTAL
Intervention: LEAP program (21-week QI training program)
Number of subjects: 68
Study: 32736596

Group type: EXPERIMENTAL
Intervention: bemcentinib
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: MEDI3506
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: acalabrutinib
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: zilucoplan
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: nebulised heparin
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 1800
Study: 35272065

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 180
Study: 33620716

Group type: EXPERIMENTAL
Intervention: Three-immune gene model including Hsp70, NOX5, and FGF23
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: High-risk group based on the three-immune gene model
Number of subjects: 493
Study: 34793245

Group type: EXPERIMENTAL
Intervention: Fosnetupitant (FosNTP) 235 mg
Number of subjects: 795

Group type: COMPARATOR
Intervention: Fosaprepitant (FosAPR) 150 mg
Number of subjects: 795
Study: 34395475

Group type: EXPERIMENTAL
Intervention: Oxygen (FiO2 0.5)
Number of subjects: 10
Study: 36037984

Group type: EXPERIMENTAL
Intervention: 30-minute SBT
Number of subjects: 100
Study: 33843335

Group type: EXPERIMENTAL
Intervention: Randomized trials in PHIR
Number of subjects: 0
Study: 33930859

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Operative treatment with 1 treatment-related SAE
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Operative treatment with 2 or more treatment-related SAEs
Number of subjects: 286

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 286
Study: 35624452

Group type: EXPERIMENTAL
Intervention: Oral sildenafil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous sildenafil
Number of subjects: 40
Study: 32828993

Group type: EXPERIMENTAL
Intervention: Osteotome technique
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 150

Group type: COMPARATOR
Intervention: Guided flapless technique
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Wider implants (3.3 × 11.5 mm vs 4.2 × 11.5 mm)
Number of subjects: 150
Study: 35225551

Group type: EXPERIMENTAL
Intervention: Glued technique of external dacryocystorhinostomy (Ext DCR) using fibrin glue
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional technique of external dacryocystorhinostomy (Ext DCR) using sutures
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups (Glued and Conventional techniques)
Number of subjects: 50
Study: 33709212

Group type: EXPERIMENTAL
Intervention: HITSystem 2.0
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 135
Study: 32735428

Group type: EXPERIMENTAL
Intervention: Foot pointed outward (FPO)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Foot pointed inward (FPI)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Foot pointed forward (FPF)
Number of subjects: 22